Income Tax Expense (Benefit) in USD of Fulgent Genetics, Inc. from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Fulgent Genetics, Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2014 to Q3 2025.
  • Fulgent Genetics, Inc. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was -$683,000.000, a 82.2% increase year-over-year.
  • Fulgent Genetics, Inc. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was -$4,617,000.000, a 73.1% increase year-over-year.
  • Fulgent Genetics, Inc. annual Income Tax Expense (Benefit) for 2024 was -$8,136,000.000, a 805% decline from 2023.
  • Fulgent Genetics, Inc. annual Income Tax Expense (Benefit) for 2023 was $1,154,000.000, a 97.3% decline from 2022.
  • Fulgent Genetics, Inc. annual Income Tax Expense (Benefit) for 2022 was $42,102,000.000, a 75.9% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Fulgent Genetics, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$4,617,000 -$683,000 +$3,155,000 +82.2% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 -$7,772,000 -$2,263,000 -$139,000 -6.5% 01 Apr 2025 30 Jun 2025 10-Q 01 Aug 2025
Q1 2025 -$7,633,000 $176,000 +$503,000 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025
Q4 2024 -$8,136,000 -$1,847,000 +$9,015,000 +83% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 -$17,151,000 -$3,838,000 -$24,164,000 -1.2% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 $7,013,000 -$2,124,000 +$986,000 +31.7% 01 Apr 2024 30 Jun 2024 10-Q 01 Aug 2025
Q1 2024 $6,027,000 -$327,000 +$4,873,000 +93.7% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025
Q4 2023 $1,154,000 -$10,862,000 -$1,476,000 -15.7% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $2,630,000 $20,326,000 +$19,912,000 +48.1% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 -$17,282,000 -$3,110,000 -$5,763,000 -2.2% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 -$11,519,000 -$5,200,000 -$53,621,000 -1.1% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024
Q4 2022 $42,102,000 -$9,386,000 -$56,534,000 -1.2% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2023
Q3 2022 $98,636,000 $414,000 -$37,131,000 -98.9% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 $135,767,000 $2,653,000 -$20,936,000 -88.8% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $156,703,000 $48,421,000 -$18,092,000 -27.2% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023
Q4 2021 $174,795,000 $47,148,000 -$11,423,000 -19.5% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023
Q3 2021 $186,218,000 $37,545,000 +$23,019,000 +1.6% 01 Jul 2021 30 Sep 2021 10-K 28 Feb 2023
Q2 2021 $163,199,000 $23,589,000 +$24,188,000 01 Apr 2021 30 Jun 2021 10-K 28 Feb 2023
Q1 2021 $139,011,000 $66,513,000 +$66,479,000 +1,955.3% 01 Jan 2021 31 Mar 2021 10-K 28 Feb 2023
Q4 2020 $72,532,000 $58,571,000 +$58,609,000 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $13,923,000 $14,526,000 +$14,465,000 +237.1% 01 Jul 2020 30 Sep 2020 10-K 28 Feb 2022
Q2 2020 -$542,000 -$599,000 -$606,000 -86.6% 01 Apr 2020 30 Jun 2020 10-K 28 Feb 2022
Q1 2020 $64,000 $34,000 +$21,000 +1.6% 01 Jan 2020 31 Mar 2020 10-K 28 Feb 2022
Q4 2019 $43,000 -$38,000 -$926,000 -1% 01 Oct 2019 31 Dec 2019 10-K 08 Mar 2021
Q3 2019 $969,000 $61,000 +$379,000 01 Jul 2019 30 Sep 2019 10-K 08 Mar 2021
Q2 2019 $590,000 $7,000 +$107,000 01 Apr 2019 30 Jun 2019 10-K 08 Mar 2021
Q1 2019 $483,000 $13,000 +$447,000 01 Jan 2019 31 Mar 2019 10-K 08 Mar 2021
Q4 2018 $36,000 $888,000 +$1,484,000 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 -$1,448,000 -$318,000 +$97,000 +23.4% 01 Jul 2018 30 Sep 2018 10-K 13 Mar 2020
Q2 2018 -$1,545,000 -$100,000 +$10,000 +9.1% 01 Apr 2018 30 Jun 2018 10-K 13 Mar 2020
Q1 2018 -$1,555,000 -$434,000 -$540,000 -5.1% 01 Jan 2018 31 Mar 2018 10-K 13 Mar 2020
Q4 2017 -$1,015,000 -$596,000 -$1,099,000 -2.2% 01 Oct 2017 31 Dec 2017 10-K 22 Mar 2019
Q3 2017 $84,000 -$415,000 -$832,000 -2% 01 Jul 2017 30 Sep 2017 10-K 22 Mar 2019
Q2 2017 $916,000 -$110,000 -$110,000 01 Apr 2017 30 Jun 2017 10-K 22 Mar 2019
Q1 2017 $1,026,000 $106,000 +$106,000 01 Jan 2017 31 Mar 2017 10-K 22 Mar 2019
Q4 2016 $920,000 $503,000 01 Oct 2016 31 Dec 2016 10-K 20 Mar 2018
Q3 2016 $417,000 +$417,000 01 Jul 2016 30 Sep 2016 10-K 20 Mar 2018
Q2 2016 $0 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 $0 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q3 2015 $0 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016

Fulgent Genetics, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$8,136,000 -$9,290,000 -8.1% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 $1,154,000 -$40,948,000 -97.3% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 $42,102,000 -$132,693,000 -75.9% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 $174,795,000 +$102,263,000 +1.4% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 $72,532,000 +$72,489,000 +1,685.8% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 $43,000 +$7,000 +19.4% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 $36,000 +$1,051,000 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
2017 -$1,015,000 -$1,935,000 -2.1% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019
2016 $920,000 +$920,000 01 Jan 2016 31 Dec 2016 10-K 20 Mar 2018
2015 $0 $0 01 Jan 2015 31 Dec 2015 10-K 17 Mar 2017
2014 $0 01 Jan 2014 31 Dec 2014 10-K 17 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.